Tom Parker doesn’t have prior government experience, characteristics the Trump administration may be seeking in its next pick to lead the cyber agency, a person familiar said.
New guidance requires incoming scholars to demonstrate skills at the intersection of AI and cybersecurity, a move that fast-tracks changes outlined in recent National Science Foundation policy.
Clean, verified data powers timely services and trust. Discover how accurate address data and FedRAMP tools reduce risk, improve delivery, and strengthen government performance.
The bill to extend Section 702 of FISA now goes to President Donald Trump’s desk. A deal worked out with lawmakers on the Senate Intelligence Committee could shed more light on the surveillance power in the coming weeks.
COMMENTARY | The cyber battlefield will continue to be the homeland, and defense agencies must continue adapting how they ensure mission continuity within it.
The initiative would bar providers on the agency’s “Covered List” from more fluid operating approval in the U.S., aiming to close a longstanding regulatory gap.
The announcement of GPT-5.5-Cyber follows Anthropic’s debut of its own Mythos AI, which the company said has already uncovered thousands of cyber vulnerabilities.
The bill now moves to the Senate, where it could face obstacles in clearing reauthorization because of a measure that bars the Federal Reserve from issuing digital currency.
The bill would require the tax agency to release detailed, real time and monthly call metrics. The House also passed a technology proposal meant to move the IRS off paper.
GOP lawmakers are seeking details on companies’ reliance on Chinese-developed systems, citing risks tied to data security, censorship and alleged AI distillation campaigns.
The move suggests the Trump administration is easing its stance on the AI company, which faced a Pentagon supply chain risk designation and phaseout directive.
The first-of-its-kind pilot could lead to speedier regulatory approval of medical drugs and devices and potentially reduce “20, 30, 40% of overall clinical trial time,” according to FDA Chief Artificial Intelligence Officer Jeremy Walsh.
COMMENTARY | The Trump administration's landmark initiative proved that consolidated, smart purchasing is not only good for government operations but also the bottom line.